Calico and AbbVie advance antiaging efforts

by Ryan Cross
June 30, 2018 | APPEARED IN VOLUME 96, ISSUE 27


AbbVie is boosting its collaboration with the secretive antiaging company Calico, which is backed by Alphabet, Google’s parent company. Both companies will contribute $500 million more to drug discovery efforts that began in 2014. A scientific publication (eLife 2018, DOI: 10.7554/eLife.32733) indicates that the duo is working with a molecule called ISRIB, integrated stress response inhibitor. Other groups previously demonstrated that ISRIB enhances memory and appears to reverse the effects of traumatic brain injury in mice.


This article has been sent to the following recipient:

Leave A Comment

*Required to comment